JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB233726

Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) is a Western equine encephalitis virus Full Length protein, expressed in HEK 293T cells, with >80%, suitable for SDS-PAGE, ELISA, WB.

View Alternative Names

Structural polyprotein, p130

3 Images
ELISA - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)
  • ELISA

Supplier Data

ELISA - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)

Plate was coated with ab233726 starting at 800 ng/well, serially diluted in DPBS. Washed plate was detected using Rabbit Anti-WEEV E2 pAb at 1 μg/mL. OD650 is reported.

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)
  • WB

Supplier Data

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)

TMB substrate

All lanes:

Anti-Western Equine Encephalitus Virus E2 rabbit polyclonal at 0.25 µg/mL

Lane 1:

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.05 µg

Lane 2:

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.1 µg

Lane 3:

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.2 µg

Secondary

All lanes:

Anti-rabbit IgG-HRP

false

SDS-PAGE - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726)

SDS-PAGE analysis of ab233726 under denaturing and reducing conditions.

Lane 1 : 1 μg

Lane 2 : 5 μg

Key facts

Purity

>80% SDS-PAGE

Expression system

HEK 293T cells

Tags

His tag C-Terminus

Applications

SDS-PAGE, ELISA, WB

applications

Biologically active

No

Accession

P13897

Animal free

No

Carrier free

No

Species

Western equine encephalitis virus

Storage buffer

Constituents: PBS, 10% Glycerol (glycerin, glycerine)

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"54 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P13897","tags":[{"tag":"His","terminus":"C-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Western Equine Encephalitis Virus E3E2 is a glycoprotein complex involved in viral entry and fusion. It is alternatively referred to as WEEV E3E2. This protein forms a heterodimer with an estimated molecular mass of approximately 50 kDa. It localizes on the viral membrane surface playing a critical role in mediating the interaction with host cell receptors. The E3E2 complex facilitates viral attachment and subsequent entry into host cells which is essential for the lifecycle of Western Equine Encephalitis Virus.
Biological function summary

The E3E2 complex initiates mechanisms important for infection. It operates as part of the viral envelope embedding within it to mediate fusion between the viral and cellular membranes. This facilitates the release of the viral genome into the host cytoplasm. The E3 segment acts as a regulatory peptide while E2 binds receptors on the host cell surface triggering fusion events. Once the virus enters the host cell it disrupts normal cellular processes to promote viral replication.

Pathways

The E3E2 glycoprotein complex interacts with host cellular processes involved in viral pathogenesis. It is intricately involved in membrane fusion pathways which are central to the viral entry process. The E3E2 complex interacts with host cell proteins such as clathrin and other components of receptor-mediated endocytosis pathways. These interactions facilitate efficient viral uptake and endosomal escape integrated into pathways important to its infectious cycle.

The E3E2 complex has a direct link with Western Equine Encephalitis a mosquito-borne viral disease affecting both equines and humans. This disease can lead to encephalitis causing inflammation of the brain. The E3E2 proteins are involved in the pathogenicity of the virus with their functions critical in leading to disease symptoms. Additionally E3E2 is relevant to studying other encephalitic viruses as it shares functional similarities with proteins from related alphaviruses providing insights into broader viral pathology.

Specifications

Form

Liquid

Additional notes

Purified by FPLC

General info

Function

Capsid protein. Forms an icosahedral capsid with a T=4 symmetry composed of 240 copies of the capsid protein surrounded by a lipid membrane through which penetrate 80 spikes composed of trimers of E1-E2 heterodimers (By similarity). The capsid protein binds to the viral RNA genome at a site adjacent to a ribosome binding site for viral genome translation following genome release (By similarity). Possesses a protease activity that results in its autocatalytic cleavage from the nascent structural protein (By similarity). Following its self-cleavage, the capsid protein transiently associates with ribosomes, and within several minutes the protein binds to viral RNA and rapidly assembles into icosahedric core particles (By similarity). The resulting nucleocapsid eventually associates with the cytoplasmic domain of the spike glycoprotein E2 at the cell membrane, leading to budding and formation of mature virions (By similarity). In case of infection, new virions attach to target cells and after clathrin-mediated endocytosis their membrane fuses with the host endosomal membrane (By similarity). This leads to the release of the nucleocapsid into the cytoplasm, followed by an uncoating event necessary for the genomic RNA to become accessible (By similarity). The uncoating might be triggered by the interaction of capsid proteins with ribosomes (By similarity). Binding of ribosomes would release the genomic RNA since the same region is genomic RNA-binding and ribosome-binding (By similarity). Specifically inhibits interleukin-1 receptor-associated kinase 1/IRAK1-dependent signaling during viral entry, representing a means by which the alphaviruses may evade innate immune detection and activation prior to viral gene expression (By similarity). Inhibits host transcription (By similarity). Forms a tetrameric complex with XPO1/CRM1 and the nuclear import receptor importin (By similarity). This complex blocks the central channel of host nuclear pores thereby inhibiting the receptor-mediated nuclear transport and thus the host mRNA and rRNA transcription (By similarity). The inhibition of transcription is linked to a cytopathic effect on the host cell (By similarity).. Assembly protein E3. Provides the signal sequence for the translocation of the precursor of protein E3/E2 to the host endoplasmic reticulum. Furin-cleaved E3 remains associated with spike glycoprotein E1 and mediates pH protection of the latter during the transport via the secretory pathway. After virion release from the host cell, the assembly protein E3 is gradually released in the extracellular space.. Spike glycoprotein E2. Plays an essential role in viral attachment to target host cell, by binding to the cell receptor. Synthesized as a pE2 precursor which is processed by furin at the cell membrane just before virion budding, giving rise to E2-E1 heterodimer. The pE2-E1 heterodimer is stable, whereas E2-E1 is unstable and dissociate at low pH. pE2 is processed at the last step, presumably to avoid E1 fusion activation before its final export to cell surface. E2 C-terminus contains a transitory transmembrane that would be disrupted by palmitoylation, resulting in reorientation of the C-terminal tail from lumenal to cytoplasmic side. This step is critical since E2 C-terminus is involved in budding by interacting with capsid proteins. This release of E2 C-terminus in cytoplasm occurs lately in protein export, and precludes premature assembly of particles at the endoplasmic reticulum membrane.. Protein 6K : Acts as a viroporin that participates in virus glycoprotein processing, cell permeabilization and budding of viral particles. Disrupts the calcium homeostasis of the cell, probably at the endoplasmic reticulum level resulting in the increased levels of cytoplasmic calcium. Because of its lipophilic properties, the 6K protein is postulated to influence the selection of lipids that interact with the transmembrane domains of the glycoproteins, which, in turn, affects the deformability of the bilayer required for the extreme curvature that occurs as budding proceeds. Present in low amount in virions, about 3% compared to viral glycoproteins.. Spike glycoprotein E1. Class II viral fusion protein. Fusion activity is inactive as long as E1 is bound to E2 in mature virion. After virus attachment to target cell and endocytosis, acidification of the endosome would induce dissociation of E1/E2 heterodimer and concomitant trimerization of the E1 subunits. This E1 trimer is fusion active, and promotes release of viral nucleocapsid in cytoplasm after endosome and viral membrane fusion. Efficient fusion requires the presence of cholesterol and sphingolipid in the target membrane.

Post-translational modifications

Structural polyprotein: Specific enzymatic cleavages in vivo yield mature proteins. Capsid protein is auto-cleaved during polyprotein translation, unmasking a signal peptide at the N-terminus of the precursor of E3/E2. The remaining polyprotein is then targeted to the host endoplasmic reticulum, where host signal peptidase cleaves it into pE2, 6K and E1 proteins. pE2 is further processed to mature E3 and E2 by host furin in trans-Golgi vesicle.. Capsid protein. Phosphorylated on serine and threonine residues.. Spike glycoprotein E2. Palmitoylated via thioester bonds. These palmitoylations may induce disruption of the C-terminus transmembrane. This would result in the reorientation of E2 C-terminus from lumenal to cytoplasmic side.. Spike glycoprotein E1. N-glycosylated.. Spike glycoprotein E2. N-glycosylated.. Assembly protein E3. N-glycosylated.. 6K protein. Palmitoylated via thioester bonds.

Subcellular localisation

Host nucleus

Product protocols

Target data

Capsid protein. Forms an icosahedral capsid with a T=4 symmetry composed of 240 copies of the capsid protein surrounded by a lipid membrane through which penetrate 80 spikes composed of trimers of E1-E2 heterodimers (By similarity). The capsid protein binds to the viral RNA genome at a site adjacent to a ribosome binding site for viral genome translation following genome release (By similarity). Possesses a protease activity that results in its autocatalytic cleavage from the nascent structural protein (By similarity). Following its self-cleavage, the capsid protein transiently associates with ribosomes, and within several minutes the protein binds to viral RNA and rapidly assembles into icosahedric core particles (By similarity). The resulting nucleocapsid eventually associates with the cytoplasmic domain of the spike glycoprotein E2 at the cell membrane, leading to budding and formation of mature virions (By similarity). In case of infection, new virions attach to target cells and after clathrin-mediated endocytosis their membrane fuses with the host endosomal membrane (By similarity). This leads to the release of the nucleocapsid into the cytoplasm, followed by an uncoating event necessary for the genomic RNA to become accessible (By similarity). The uncoating might be triggered by the interaction of capsid proteins with ribosomes (By similarity). Binding of ribosomes would release the genomic RNA since the same region is genomic RNA-binding and ribosome-binding (By similarity). Specifically inhibits interleukin-1 receptor-associated kinase 1/IRAK1-dependent signaling during viral entry, representing a means by which the alphaviruses may evade innate immune detection and activation prior to viral gene expression (By similarity). Inhibits host transcription (By similarity). Forms a tetrameric complex with XPO1/CRM1 and the nuclear import receptor importin (By similarity). This complex blocks the central channel of host nuclear pores thereby inhibiting the receptor-mediated nuclear transport and thus the host mRNA and rRNA transcription (By similarity). The inhibition of transcription is linked to a cytopathic effect on the host cell (By similarity).. Assembly protein E3. Provides the signal sequence for the translocation of the precursor of protein E3/E2 to the host endoplasmic reticulum. Furin-cleaved E3 remains associated with spike glycoprotein E1 and mediates pH protection of the latter during the transport via the secretory pathway. After virion release from the host cell, the assembly protein E3 is gradually released in the extracellular space.. Spike glycoprotein E2. Plays an essential role in viral attachment to target host cell, by binding to the cell receptor. Synthesized as a pE2 precursor which is processed by furin at the cell membrane just before virion budding, giving rise to E2-E1 heterodimer. The pE2-E1 heterodimer is stable, whereas E2-E1 is unstable and dissociate at low pH. pE2 is processed at the last step, presumably to avoid E1 fusion activation before its final export to cell surface. E2 C-terminus contains a transitory transmembrane that would be disrupted by palmitoylation, resulting in reorientation of the C-terminal tail from lumenal to cytoplasmic side. This step is critical since E2 C-terminus is involved in budding by interacting with capsid proteins. This release of E2 C-terminus in cytoplasm occurs lately in protein export, and precludes premature assembly of particles at the endoplasmic reticulum membrane.. Protein 6K : Acts as a viroporin that participates in virus glycoprotein processing, cell permeabilization and budding of viral particles. Disrupts the calcium homeostasis of the cell, probably at the endoplasmic reticulum level resulting in the increased levels of cytoplasmic calcium. Because of its lipophilic properties, the 6K protein is postulated to influence the selection of lipids that interact with the transmembrane domains of the glycoproteins, which, in turn, affects the deformability of the bilayer required for the extreme curvature that occurs as budding proceeds. Present in low amount in virions, about 3% compared to viral glycoproteins.. Spike glycoprotein E1. Class II viral fusion protein. Fusion activity is inactive as long as E1 is bound to E2 in mature virion. After virus attachment to target cell and endocytosis, acidification of the endosome would induce dissociation of E1/E2 heterodimer and concomitant trimerization of the E1 subunits. This E1 trimer is fusion active, and promotes release of viral nucleocapsid in cytoplasm after endosome and viral membrane fusion. Efficient fusion requires the presence of cholesterol and sphingolipid in the target membrane.
See full target information Structural polyprotein

Additional targets

Western Equine Encephalitis Virus E3E2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com